Ads
related to: Gastroenterology
Search results
Salix to Present Late-Breaking Data from Phase 2 Trial of Amiselimod in Active Ulcerative Colitis at...
Digital Journal· 4 days agoLAVAL, QC / ACCESSWIRE / May 17, 2024 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) and its gastroenterology (GI) business, Salix Pharmaceuticals, today announced that ...
The FODMAP diet: Benefits, downsides and foods to avoid
Daily Telegraph· 4 days ago“Many good quality trials have shown the diet to be effective in significantly reducing IBS...
Bausch Health Announces Updates Related to Norwich XIFAXAN Matters
Digital Journal· 6 days ago(NYSE:BHC)(TSX:BHC) and its gastroenterology business Salix Pharmaceuticals, today announced certain updates related to its litigation with Norwich Pharmaceuticals, Inc. With ...
Yes, Spices Can Help You Lose Weight—Start With These 15 Options
Parade via AOL· 4 days ago“Mint improves alertness, boosts overall mood and reduces the feeling of fatigue,” Dr. Siamak Tabib,...
Low-FODMAP, Low-Carb Diets May Beat Medical Tx for IBS
Medscape· 18 hours agoDietary interventions could be considered as an initial treatment for patients with IBS, although...
AbbVie Presents New Data Supporting Leading Gastroenterology Portfolio at 2024 Digestive Disease...
Tri-County Times· 4 days ago- AbbVie will present 15 abstracts, including three oral presentations, in Crohn's disease and ulcerative colitis reinforcing AbbVie's commitment to advancing the standards of care in inflammatory bowel diseases (IBD)
New thesis shows Lynch syndrome should be seen as a common condition
Medical Xpress· 3 hours agoThe main supervisor is Ann-Sofie Backman (MedH). "We have investigated various risk factors associated with the development of colorectal cancer in Lynch syndrome and what it is like for these ...
To Boost Colon Cancer Screening, Give Patients Choices
WFMZ Eastern Pennsylvania and Western New Jersey· 13 hours agoGiving patients a choice between screening methods could help doctors detect colon cancer earlier, a...
ZYMFENTRA™ (infliximab-dyyb) demonstrated long-term efficacy and safety profile of maintenance...
The Pendulum· 19 hours agoCelltrion USA announced today positive two-year results from the extended LIBERTY studies (LIBERTY-CD and LIBERTY-UC) for ZYMFENTRA™ (infliximab-dyyb) in adult patients with moderately to severely ...
New guideline: Barrett's esophagus precedes esophageal cancer, but not all patients need abnormal...
Medical Xpress· 5 days agoA precursor to esophageal cancer, Barrett's esophagus is a condition in which the cells in the esophagus have been replaced with non-cancerous abnormal cells.